Implantable Biomarker Sensor Using Capacitance-Shift Oscillator

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current methods for detecting biomarkers in animals are invasive, time-consuming, and require frequent manual sampling, leading to intermittent monitoring and potential undetected health issues, with existing electrochemical sensors facing challenges in stability, storage, and functionality in diverse biological samples.

Innovation Solution

An implantable device using terahertz sensors based on dielectric spectroscopy with a pair of electrodes and an oscillator that changes frequency in response to biomarkers in biological fluid, integrated with a transponder for wireless communication and a biocompatible housing, allowing for continuous, non-invasive monitoring.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Measurement precision

If manual sampling methods are used to detect biomarkers, then detection accuracy can be maintained, but monitoring becomes intermittent and time-consuming requiring frequent human intervention

Engineering Contradiction:
Improvebiomarker detection accuracyVSAvoidmonitoring efficiency
Core Design Contradiction:
Measurement precisionVSProductivity

Solution Approach 1:

The implantable device performs self-monitoring by automatically detecting biomarkers in biological fluid through integrated electrochemical sensors, eliminating the need for manual sampling and human intervention. The device continuously monitors health parameters and communicates data wirelessly, enabling autonomous health tracking without requiring veterinary personnel.

Inventive Principle:
Principle #25Self-service

Solution Approach 2:

The patent replaces manual mechanical sampling procedures with an automated electrochemical sensing system. The sensor detects biomarkers through electrical signals in biological fluid, substituting the mechanical act of blood drawing and manual analysis with an automated electronic detection system that operates continuously.

Inventive Principle:
Principle #28Mechanics substitution (Replace mechanical system)

2Reliability

If frequent manual sampling is performed to ensure continuous monitoring, then health issues can be detected promptly, but the process becomes invasive and distressing for the animal

Engineering Contradiction:
Improvemonitoring continuityVSAvoidanimal distress and invasion
Core Design Contradiction:
ReliabilityVSObject-affected harmful factors

Solution Approach 1:

The device enables continuous self-monitoring by automatically detecting biomarkers in biological fluid through integrated electrochemical sensors, eliminating the need for manual sampling and human intervention. The device continuously monitors health parameters and communicates data wirelessly, enabling autonomous health tracking without requiring veterinary personnel.

Inventive Principle:
Principle #25Self-service

Solution Approach 2:

The implantable device acts as an intermediary between the animal's biological system and external monitoring. It continuously samples biological fluid through an implanted sensor, processes the data, and communicates health status externally, eliminating the need for repeated invasive manual sampling and animal handling.

Inventive Principle:
Principle #24Intermediary (Mediator)

3Extent of automation

If electrochemical sensors are used for biomarker detection, then monitoring can be automated, but challenges remain in optimizing stability, storage, and functionality in diverse biological samples

Engineering Contradiction:
Improvemonitoring automationVSAvoidsensor stability and functionality
Core Design Contradiction:
Extent of automationVSReliability

Solution Approach 1:

The patent optimizes sensor performance by adjusting electrochemical parameters including operating potential, reference electrode selection, and sensor geometry. The device modifies detection parameters to accommodate diverse biological samples, enhancing sensor stability and reliability across different physiological conditions and animal types.

Inventive Principle:
Principle #35Parameter changes

Solution Approach 2:

The sensor employs composite material structures combining different electrochemical materials with complementary properties. This includes using multiple electrode materials with different selectivities and incorporating protective coatings that enhance stability in biological environments while maintaining detection functionality.

Inventive Principle:
Principle #40Composite materials

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The device provides continuous, accurate biomarker detection with improved sensitivity and reproducibility, reducing the need for frequent sampling and manual intervention, while maintaining a small size and high integration for easy implantation, offering a more efficient and effective monitoring solution.

Implementation Method 1

The implantable device is based on the dielectric spectroscopy principle for detecting the biomarkers biological fluid of animals.

Methodology Applied
Scientific EffectDielectric spectroscopy: Dielectric Permittivity

Implementation Method 2

the biological fluid causes the capacitance of the pair of electrodes to change from the first capacitance to a second capacitance

Methodology Applied
Scientific EffectCapacitance change: Capacitance

Data Source

PatentUS20240225446A9Implantable device
Publication Date: 2024.07.11 CHORDATA LTD
  • US20240225446A9 patent drawing
  • US20240225446A9 patent drawing
  • US20240225446A9 patent drawing

AI summary

An implantable device for detecting biomarkers in animals, the device comprises: a sensor comprising: a pair of electrodes spaced apart from each other, the pair of electrodes having a first capacitance; an oscillator configured to oscillate at a first frequency and output a first signal at the first frequency; wherein the sensor is configured to receive an amount of biological fluid wherein the biological fluid causes the capacitance of the pair of electrodes to change from the first capacitance to a second capacitance; wherein the oscillator is coupled to the pair of electrodes and arranged such that a change in the capacitance of the pair of electrodes causes a change in oscillation of the oscillator from the first frequency to a second frequency; and wherein the oscillator is configured to output a second signal at the second frequency, the second signal indicative of a biomarker in the biological fluid.